Immunohistochemical localization and functional characterization of somatostatin receptor subtypes in a corticotropin releasing hormone-secreting adrenal phaeochromocytoma: Review of the literature and report of a case

European Journal of Histochemistry

Volumn 53, Issue 1, 2009, Pages 1-6

  Ruggeri, Rosaria M ^a   Ferrau F ^a   Campenni A ^a   Simone, A ^a   Barresi, V ^a   Giuffre G ^a   Tuccari, G ^a   Baldari, S ^a   Trimarchi, F ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Corticotropin releasing hormone; Neuroendocrine tumours; Octreotide; Phaeochromocytoma; Somatostatin receptors

Indexed keywords

ADRENALIN; ANTISERUM; CHROMOGRANIN A; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; FORMALDEHYDE; HYDROCORTISONE; METADRENALIN; NORMETADRENALIN; OCTREOTIDE; PARAFFIN; PENTETATE INDIUM IN 111; PENTETREOTIDE; PROTEIN S 100; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 2A; SOMATOSTATIN RECEPTOR 2B; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR TYPE 1;

ADRENAL GLAND; ADRENAL TUMOR; ADRENALIN URINE LEVEL; ADULT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CUSHING DISEASE; FEMALE; HISTOPATHOLOGY; HORMONE SYNTHESIS; HORMONE URINE LEVEL; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPERTENSION; HYPOKALEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LAPAROSCOPIC SURGERY; NEUROFILAMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SCINTIGRAPHY; TUMOR CELL; URINARY EXCRETION; WHOLE BODY SCINTISCANNING; METABOLISM; PATHOLOGY; SECRETION;

ADRENAL GLAND NEOPLASMS; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OCTREOTIDE; PHEOCHROMOCYTOMA; RECEPTORS, SOMATOSTATIN;

EID: 66149116800     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/ejh.2009.e1     Document Type: Review

References (20)

1. Bayraktar F, Kebapcilar L, Kocdor MA, Asa SL, Yesil S, Canda S, et al. Cushing's syndrome due to ectopic CRH-secretion by adrenal phaeochromocytoma accompanied by renal infarction. Exp Clin Endocrinol Diabetes 2006;114:444-447 (Pubitemid 44620489)
2. Chen H, Doppman JL, Chrousos GP, Norton JA, Nieman LK, Udelsman R. Adrenocorticotropic hormone-secreting phaeochromocytomas: the exception to the rule. Surgery 1995; 118: 988-995
3. de Herder WW and Hofland LJ. Somatostatin receptors in pheochromocytoma. Front Horm Res 2004;31: 145-154
4. Eng PH, Tan LH, Wong KS, Cheng CW, Fok AC, Khoo DH. Cushing's syndrome in a patient with a corticotropin-releasing hormone-producing phaeochromocytoma. Endocr Pract 1999;5: 84-87
5. Epelbaum J, Bertherat J, Prevost G, Kordon C, Meyerhof W, Wulfsen I, et al. (1995). Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal, and malignant pheochromocytomas. J Clin Endocrinol Metab 1995;80:1837-1844
6. Hofland LJ, Liu Q, van Koetsveld PM, Zuiderwijk J, van der Ham F, de Krijger RR, et al. Immunhistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors. J Clin Endocrinol Metab 1999;84:775-780 (Pubitemid 29075720)
7. Invitti C, De Martin I, Bolla GB, Pecori Giraldi F, Maestri E, Leonetti G, et al. Effect of octreotide on catecholamine plasma levels in patients with chromaffin cell tumors. Horm Res 1993;40:156-160 (Pubitemid 24008272)
8. Kopf D, Bockisch A, Steinert H, Hahn K, Beyer J, Neumann HP, et al. Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant phaeochromocytoma. Clin Endocrinol (Oxf) 1997;46:39-44. (Pubitemid 27072844)
9. Kubota A, Yamada Y, Kagimoto S, Shimatsu A, Imamura M, Tsuda K, et al. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest 1994;93:1321-1325 (Pubitemid 24087192)
10. Lamarre-Cliche M, Gimenez-Roqueplo AP, Billaud E, Baudin E, Luton JP, Plouin PF. Effects of slow-release octreotide on urinary metanephrine excretion and plasma chromogranin A and catecholamine levels in patients with malignant or recurrent phaeochromocytoma. Clin Endocrinol (Oxf) 2002;57:629-634 (Pubitemid 35316980)
11. Mundschenk J, Unger N, Schulz S, Höllt V, Schulz S, Steinke R, et al. Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy. J Clin Endocrinol Metab 2003;88:5150-5157 (Pubitemid 37452710)
12. O'Brien T, Young WF, Davila DG, Scheithauer BW, Kovacs K, Horvath E, et al. Cushing's syndrome associated with ectopic production of corticotropin-releasing hormone, corticotropin and vasopressin by a phaeochromocytoma. Clin Endocrinol (Oxf) 1992;37:460-467
13. Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS. Recent advances in genetics, diagnostic, localization and treatment of phaeochromocytomas. Ann Intern Med 2001;134:315-329 (Pubitemid 32163955)
14. Pasquali D, Rossi V, Conzo G, Pannone G, Bufo P, De Bellis A, et al. Effects of somatostatin analog SOM230 on cell proliferation, apoptosis, and catecholamine levels in cultured pheochromocytoma cells. J Mol Endocrinol 2008;40:263-271 (Pubitemid 351865034)
15. Plouin PF, Bertherat J, Chatellier G, Billaud E, Azizi M, Grouzmann E et al. Short-term effects of octreotide on blood pressure and plasma catecholamines and neuropeptide Y levels in patients with phaeochromocytoma: a placebo-controlled trial. Clin Endocrinol (Oxf) 1995;42:289-294
16. Reubi JC, Waser B, Khosla S, Kvols L, Goellner JR, Krenning E et al. In vitro and in vivo detection of somatostatin receptors in pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 1992;74:1082-1089
17. Ueberberg B, Tourne H, Redman A, Walz MK, Schmid KW, Mann K, et al. Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland. Horm Metab Res 2005;37:722-728 (Pubitemid 43028072)
18. Unger N, Serdiuk I, Sheu SY, Walz MK, Schulz S, Schmid KW et al. Immunoistochemical determination of somatostatin receptor subtypes 1, 2a, 3, 4 and 5 in various adrenal tumours. Endocrine Res 2004;30:931-934
19. Unger N, Serdiuk I, Sheu SY, Walz MK, Schulz S, Saeger W, et al. Immunohistochemical localization of somatostatin receptor subtypes in benign and malignant adrenal tumors. Clin Endocrinol (Oxf) 2008;68:850-857 (Pubitemid 351703940)
20. White A, Ray DW, Talbot A, Abraham P, Thody AJ, Bevan JS. Cushing's syndrome due to phaeochromocytoma secreting the precursors of adrenocorticotropin. J Clin Endocrinol Metab 2000;85: 4771-4775 (Pubitemid 32162142)